TTOO T2 BiosystemsWatchlist
About T2 Biosystems Company
T2 Biosystems, Inc. engages in the development of a proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables detection of pathogens, biomarkers, and other abnormalities in a range of unpurified patient sample types. The firm's products include the T2Dx Instrument, the T2Candida Panel, the T2Bacteria Panel, the T2Resistance Panel, and the T2SARS-CoV-2 Panel. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
CR Group Sells Another $1.3M Shares in T2 Biosystems, Shares Fall
T2 Biosystems(TTOO.US) 10% Shareholder Sells US$1.31 Million in Common Stocks
$T2 Biosystems(TTOO.US)$ 10% Shareholder CR Group L.P. sold 5.08 million shares of Common Stocks on Sep 22, 2023 at an average price of $0.2588 for a total value of $1.31 million. This transaction inv
T2 Biosystems Investor CR Group Sells $1.9M in Common Stock
Back in the 1980’s during the height of the Cold War Ronald Reagan made the decision to rapidly increase military spending, particularly on nuclear weapons in order to destroy the Soviet Union without firing a single bullet. His plan worked and the Soviet Union collapsed because they did not have the money to keep pace with the USA without going bankrupt. Few people know where this idea was born. The USA was using its s...